Merck & Co., Inc. (MRK)

Merck & Co. Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	6,841	12,694	8,096	8,050	9,676
Short-Term Investments	252	498	0	0	774
Cash & Cash Equivalents	7,093	13,192	8,096	8,050	10,450
Cash Growth	-46.23%	62.94%	0.57%	-22.97%	17.89%
Receivables	10,349	9,450	9,230	6,803	6,778
Inventory	6,358	5,911	5,953	5,554	5,978
Other Current Assets	8,368	7,169	6,987	7,357	4,277
Total Current Assets	32,168	35,722	30,266	27,764	27,483
Property, Plant & Equipment	23,051	21,422	19,279	17,000	15,053
Long-Term Investments	252	1,015	370	785	1,469
Goodwill and Intangibles	39,208	41,473	44,197	32,983	33,621
Other Long-Term Assets	11,996	9,528	11,582	13,056	6,771
Total Long-Term Assets	74,507	73,438	75,428	63,824	56,914
Total Assets	106,675	109,160	105,694	91,588	84,397
Accounts Payable	3,922	4,264	4,609	4,327	3,738
Current Debt	1,372	1,946	2,412	6,431	3,610
Other Current Liabilities	20,400	18,029	16,851	16,569	14,872
Total Current Liabilities	25,694	24,239	23,872	27,327	22,220
Long-Term Debt	33,683	28,745	30,690	25,360	22,736
Other Long-Term Liabilities	9,663	10,118	12,875	13,497	13,440
Total Long-Term Liabilities	43,346	38,863	43,565	38,857	36,176
Total Liabilities	69,040	63,102	67,437	66,184	58,396
Total Debt	35,055	30,691	33,102	31,791	26,346
Debt Growth	14.22%	-7.28%	4.12%	20.67%	4.91%
Retained Earnings	53,895	61,081	53,696	47,362	46,602
Comprehensive Income	-5,161	-4,768	-4,429	-6,634	-6,193
Shareholders' Equity	37,581	45,991	38,184	25,317	25,907
Net Cash / Debt	-27,962	-17,499	-25,006	-23,741	-15,896
Net Cash Per Share	-10.98	-6.88	-9.85	-9.34	-6.16
Working Capital	6,474	11,483	6,394	437	5,263
Book Value Per Share	14.81	18.16	15.09	10.01	10.10

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).